α1-Adrenergic agonists have recently been found to potentiate vasoactive intestinal peptide (VIP) stimulation of rat pinealocyte cAMP and cGMP. α1-Adrenergic agonists also elevate pineal intracellular Ca2+ ([Ca2+]i) and activate protein kinase-C. In the present study, the possible involvement of Ca2+ and protein kinase-C in the aradrenergic potentiation of VIPstimulated cAMP and cGMP accumulation was examined with agents that alter [Ca2+]i or activate protein kinase-C. It was found that treatment with a Ca2+ chelator or with inorganic Ca2+ channel blockers inhibited aradrenergic potentiation of VIPstimulated cAMP and cGMP responses. Increasing [Ca2+]i by treatment with A23187, ouabα1n, or K+ potentiated VIP stimulation of cAMP and cGMP response. These observations indicate that Ca2+ mediates the α1-adrenergic potentiation of VIPstimulated cAMP and cGMP accumulation, as is true for the α1-adrenergic potentiation ofβ-adrenergic stimulated cAMP and cGMP accumulation. Activators of protein kinase-C mimicked the large effect aradrenergic agonists have on cAMP accumulation in VIP-treated pinealocytes and had a small effect on cGMP accumulation in VIP-treated cells. These effects were not blocked by the Ca2+ chelator EGTA. However, the effects of a protein kinase-C activator on the cGMP response in VlP-stimulated cells were amplified by K+ (15 mM) or ouabα1n (1 μM), presumably through an action causing an increase in [Ca2+]i. These results suggest protein kinase-C is involved in the α1adrenergic potentiation of VIP-stimulated cAMP accumulation, as is the case for the α1-adrenergic potentiation of β-adrenergic stimulated cAMP. Protein kinase-C is also involved in cGMP accumulation, provided that there is a modest increase in [Ca2+]i. (Endocrinology122: 702–708, 1988)

This content is only available as a PDF.
You do not currently have access to this article.